A detailed history of Shell Asset Management CO transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 6,035 shares of VERV stock, worth $34,821. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,035
Previous 5,769 4.61%
Holding current value
$34,821
Previous $28,000 3.57%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$4.4 - $7.86 $1,170 - $2,090
266 Added 4.61%
6,035 $29,000
Q1 2024

Jul 31, 2024

SELL
$10.81 - $17.96 $3,815 - $6,339
-353 Reduced 5.77%
5,769 $28,000
Q1 2024

May 14, 2024

SELL
$10.81 - $17.96 $3,178 - $5,280
-294 Reduced 4.58%
6,122 $81,000
Q4 2023

Feb 14, 2024

BUY
$8.84 - $18.7 $56,717 - $119,979
6,416 New
6,416 $89,000

Others Institutions Holding VERV

About Verve Therapeutics, Inc.


  • Ticker VERV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,942,300
  • Market Cap $346M
  • Description
  • Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...
More about VERV
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.